Scorpion Toxin Polyptides as Therapeutic Agents: An Overview
Journal:
Protein & Peptide Letters
Volume:
23
Page:
848-859
Author(s):
Janardhan Bhavya, Niyonzima N. Francois, Veena S. More and Sunil S. More
Protein Engineering Studies for C-C Chemokine Receptor Type 2 (CCR2)
Journal:
Current Enzyme Inhibition
Volume:
12
Page:
110-114
Author(s):
Ramin E. Salmas, Mine Yurtsever and Serdar Durdagi
Biochemical Markers of Renal Function
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
2018-2040
Author(s):
Danijela Krstic, Nenad Tomic, Branimir Radosavljevic, Natasa Avramovic, Vesna Dragutinovic, Sanja Radojevic Skodric and Mirjana Colovic
Nanocarriers as Tools in Delivering Active Compounds for Immune System Related Pathologies
Journal:
Recent Patents on Nanotechnology
Volume:
10
Page:
128-145
Author(s):
Codruta Soica, Dorina Coricovac, Cristina Dehelean, Iulia Pinzaru, Marius Mioc, Corina Danciu, Adriana Fulias, Maria Puiu and Cassian Sitaru
Metformin - The Drug for the Treatment of Autoimmune Diseases; A New Use of a Known Anti-Diabetic Drug
Journal:
Current Topics in Medicinal Chemistry
Volume:
16
Page:
2223-2230
Author(s):
Malgorzata Tomczynska, Michal Bijak and Joanna Saluk
Immune-Regulatory Mechanisms of Classical and Experimental Multiple Sclerosis Drugs: A Special Focus on Helminth-Derived Treatments
Journal:
Current Medicinal Chemistry
Volume:
23
Page:
1152-1170
Author(s):
Alberto N. Peón and Luis I. Terrazas
Vaccination and Induction of Autoimmune Diseases
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
14
Page:
94-98
Author(s):
Éric Toussirot and Matthieu Bereau
The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations
Journal:
Current Drug Targets
Volume:
17
Page:
651-665
Author(s):
David M. Kofler, Aron Farkas, Michael von Bergwelt-Baildon and David A. Hafler
Editorial (Thematic Issues: Heads Or Tails: Betting On CD6 As a Resurged Target For Autoimmune Diseases and Sepsis)
Journal:
Current Drug Targets
Volume:
17
Page:
618-618
Author(s):
Alexandre M. Carmo
Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab
Journal:
Current Drug Targets
Volume:
17
Page:
666-677
Author(s):
Patricia Hernández, Ernesto Moreno, Lazaro E. Aira and Pedro C. Rodríguez